Joseph J. Drabick

ScholarGPS® ID: 83676750930026

Affiliation

Pennsylvania State University, University Park, United States

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

175

Predicted Citations

5,806

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma (journal article) Hiller, Andrea \| Oxford, Madison \| Kulkarni, Pallavi \| Fornadley, Jeffrey \| Lo, Alexis \| Sivik, Jeffrey \| Drabick, Joseph \| Vakharia, Kavita Annals of Plastic Surgery, volume 92, issue 4S, pages S129-S131 (2024). 10.1097/SAP.0000000000003847 Cite \| Source
IMMU-02. IS DUAL AGENT IMMUNOTHERAPY SHIFTING THE EPIDEMIOLOGY OF MELANOMA BRAIN METASTASES? A REAL-WORLD ANALYSIS AND SINGLE-INSTITUTION VALIDATION (journal article) Bhanja, Debarati \| Wilding, Hannah \| Moeckel, Camille \| Hong, Jinpyo \| Baroz, Angel \| Stahl, Caleb \| Ozair, Ahmad \| Dao, Joseph \| Sivik, Jeff \| Drabick, Joseph \| ... \| Mansouri, Alireza Neuro-Oncology, volume 25, issue Supplement_5, pages v141-v141 (2023). 10.1093/neuonc/noad179.0534 Cite \| Source
The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (VCR) in Treating Mantle Cell Lymphoma (journal article) Pu, Jeffrey J. \| Berger, Kristin \| Zheng, Chunlei \| Do, Nhan V \| Claxton, David F. \| Ehmann, W Christopher \| Drabick, Joseph J. \| Loughran, Thomas P. \| Epner, Elliot Blood, volume 142, issue Supplement 1, pages 6152-6152 (2023). 10.1182/blood-2023-185797 Cite \| Source
P06.01.A HAS THE USE OF DUAL AGENT IMMUNOTHERAPY BEEN ALTERING THE INCIDENCE OF MELANOMA BRAIN METASTASES? A POPULATION-LEVEL ANALYSIS AND SINGLE-INSTITUTION VALIDATION (journal article) Salmanian, S \| Bhanja, D \| Wilding, H \| Moeckel, C \| Hong, J \| Dao, J \| Baroz, A \| Stahl, C \| Sivik, J \| Drabick, J \| ... \| Mansouri, A Neuro-Oncology, volume 25, issue Supplement_2, pages ii44-ii44 (2023). 10.1093/neuonc/noad137.141 Cite \| Source
A phase 2 study of alrizomadlin (APG-115) in combination with pembrolizumab in patients with unresectable or metastatic cutaneous melanoma that has failed immuno-oncologic (IO) drugs. (journal article) Shaheen, Montaser F. \| Segar, Jennifer Margaret \| Chmielowski, Bartosz \| Drabick, Joseph J. \| McKean, Meredith \| Reeves, James A. \| Karapetis, Christos Stelios \| Orloff, Marlana M. \| Tolcher, Anthony W. \| Beck, J. Thaddeus Thaddeus \| ... \| Zhai, Yifan Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 9559-9559 (2023). 10.1200/JCO.2023.41.16_suppl.9559 Cited by (4) \| Cite \| Source
Multimodal machine learning analysis of more than 220,000 tumor profiles to diagnose molecular and morphological subtypes of cancer. (journal article) Abraham, Jim \| Klimov, Sergey \| Amidi, Eghbal \| Heimberger, Amy B. \| Marshall, John \| Heath, Elisabeth I. \| Drabick, Joseph J. \| Rubin, Brian \| Ali-Fehmi, Rouba \| Braxton, David R. \| ... \| Spetzler, David Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 3078-3078 (2023). 10.1200/JCO.2023.41.16_suppl.3078 Cite \| Source
Non-Selective β-Blocker Use in the Treatment of Stewart-Treves Syndrome (journal article) Axcell, Kent \| Kim, Yesul \| Fox, Edward J. \| Drabick, Joseph J. \| Anderson, Bryan E. Consultant (2023). 10.25270/con.2023.01.000006 Cite \| Source
Effect of bone metastasis on outcomes in the CCTG BR.34 phase II randomized trial of dual immune checkpoint inhibitor (ICI) treatment with or without chemotherapy in high-risk, stage IVA/B NSCLC. (journal article) Leitzel, Kim \| Ali, Suhail M. \| Ding, Keyue \| Leighl, Natasha B. \| Vera Badillo, Francisco Emilio \| Gaudreau, Pierre-Olivier \| Bradbury, Penelope Ann \| Goss, Glenwood D. \| Shepherd, Lois E. \| Costa, Luis \| ... \| Lipton, Allan Journal of Clinical Oncology, volume 40, issue 16_suppl, pages 9067-9067 (2022). 10.1200/JCO.2022.40.16_suppl.9067 Cited by (1) \| Cite \| Source
Group-led creative writing and behavioural health in cancer: a randomised clinical trial (journal article) Nesterova, Darya \| Zhu, Junjia \| Kramer, Courtney \| Vasekar, Monali \| Truica, Cristina \| Joshi, Aditya \| Hayes, Michael \| Kessler, Jolene \| Saunders, Erika F H \| Drabick, Joseph J \| Joshi, Monika BMJ Supportive & Palliative Care, volume 12, issue 1, pages 91-98 (2022). 10.1136/bmjspcare-2020-002463 Cited by (6) \| Cite \| Source
Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study (journal article) Joshi, Monika \| Holder, Sheldon L. \| Zhu, Junjia \| Zheng, Hong \| Komanduri, Shraddha \| Warrick, Joshua \| Yasin, Hesham \| Garje, Rohan \| Jia, Bei \| Drabick, Joseph J. \| ... \| Zakharia, Yousef European Urology Focus, volume 8, issue 2, pages 483-490 (2022). 10.1016/j.euf.2021.03.005 Cited by (2) \| Cite \| Source
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation (journal article) Spengler, Marianne \| Wheelden, Megan \| Mackley, Heath B. \| Drabick, Joseph J. JCO Precision Oncology (2021). 10.1200/PO.20.00486 Cited by (5) \| Cite \| Source
Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US (journal article) Zaorsky, Nicholas G. \| Khunsriraksakul, Chachrit \| Acri, Samantha L. \| Liu, Dajiang J. \| Ba, Djibril M. \| Lin, John L. \| Liu, Guodong \| Segel, Joel E. \| Drabick, Joseph J. \| Mackley, Heath B. \| Leslie, Douglas L. JAMA Network Open, volume 4, issue 10, pages e2127784- (2021). 10.1001/jamanetworkopen.2021.27784 Cited by (13) \| Cite \| Source
Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies (journal article) Tchelebi, Leila T \| Batchelder, Emma \| Wang, Ming \| Lehrer, Eric J \| Drabick, Joseph J \| Sharma, Navesh \| Machtay, Mitchell \| Trifiletti, Daniel M \| Zaorsky, Nicholas G JNCI Cancer Spectrum, volume 5, issue 4 (2021). 10.1093/jncics/pkab050 Cited by (16) \| Cite \| Source
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma (journal article) Zakharia, Yousef \| McWilliams, Robert R \| Rixe, Olivier \| Drabick, Joseph \| Shaheen, Montaser F \| Grossmann, Kenneth F \| Kolhe, Ravindra \| Pacholczyk, Rafal \| Sadek, Ramses \| Tennant, Lucinda L \| ... \| Milhem, Mohammed Journal for ImmunoTherapy of Cancer, volume 9, issue 6, pages e002057- (2021). 10.1136/jitc-2020-002057 Cited by (46) \| Cite \| Source
Preliminary results of a phase II study of alrizomadlin (APG-115), a novel, small-molecule MDM2 inhibitor, in combination with pembrolizumab in patients (pts) with unresectable or metastatic melanoma or advanced solid tumors that have failed immuno-oncolo (journal article) Tolcher, Anthony W. \| Reeves, James Andrew \| McKean, Meredith \| Chmielowski, Bartosz \| Beck, Joseph Thaddeus \| Shaheen, Montaser F. \| Somaiah, Neeta \| Wilson, Melissa \| Spira, Alexander I. \| Drabick, Joseph J. \| ... \| Zhai, Yifan Journal of Clinical Oncology, volume 39, issue 15_suppl, pages 2506-2506 (2021). 10.1200/JCO.2021.39.15_suppl.2506 Cited by (14) \| Cite \| Source
The exercise in all chemotherapy trial (journal article) Schmitz, Kathryn H. \| Potiaumpai, Melanie \| Schleicher, Erica A. \| Wolf, Laura J. \| Doerksen, Shawna E. \| Drabick, Joseph J. \| Yee, Nelson S. \| Truica, Cristina I. \| Mohamed, Ali A. \| Shaw, Bethany W. \| Farley, Diane C. Cancer, volume 127, issue 9, pages 1507-1516 (2021). 10.1002/cncr.33390 Cited by (8) \| Cite \| Source
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type (journal article) Abraham, Jim \| Heimberger, Amy B. \| Marshall, John \| Heath, Elisabeth \| Drabick, Joseph \| Helmstetter, Anthony \| Xiu, Joanne \| Magee, Daniel \| Stafford, Phillip \| Nabhan, Chadi \| ... \| Spetzler, David Translational Oncology, volume 14, issue 3, pages 101016- (2021). 10.1016/j.tranon.2021.101016 Cited by (19) \| Cite \| Source
Phase II clinical study of concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: Results for primary analyses and survival. BTCRC-GU15-023. (journal article) Joshi, Monika \| Kaag, Matthew \| Tuanquin, Leonard \| Liao, Jason \| Kilari, Deepak \| Emamekhoo, Hamid \| Sankin, Alexander \| Merrill, Suzanne B \| Zheng, Hong \| Holder, Sheldon L. \| ... \| Zakharia, Yousef Journal of Clinical Oncology, volume 39, issue 6_suppl, pages 398-398 (2021). 10.1200/JCO.2021.39.6_suppl.398 Cited by (7) \| Cite \| Source
A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia (journal article) Zheng, Hong \| Mineishi, Shin \| Claxton, David \| Zhu, Junjia \| Zhao, Chenchen \| Jia, Bei \| Ehmann, W. Christopher \| Rybka, Witold B. \| Naik, Seema \| Songdej, Natthapol \| ... \| Hohl, Raymond J. American Journal of Hematology, volume 96, issue 2 (2021). 10.1002/ajh.26043 Cited by (19) \| Cite \| Source
Postoperative chemotherapy and radiation improve survival following cardiac sarcoma resection (journal article) Hendriksen, Brandon S. \| Stahl, Kelly A. \| Hollenbeak, Christopher S. \| Taylor, Matthew D. \| Vasekar, Monali K. \| Drabick, Joseph J. \| Conte, John V. \| Soleimani, Behzad \| Reed, Michael F. The Journal of Thoracic and Cardiovascular Surgery, volume 161, issue 1, pages 110-119.e4 (2021). 10.1016/j.jtcvs.2019.10.016 Cited by (21) \| Cite \| Source